Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer

NCT00609622 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

191

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description.

Conditions

Colorectal Neoplasms

Interventions

DRUG: sunitinib
DRUG: mFOLFOX6
DRUG: bevacizumab
DRUG: mFOLFOX6

Sponsor

Pfizer